I also have rosacea, which has flared due to the vaccine, as of the next day after vaccine.; red rash on my arm 4 inches by 4 inches around the area of injection, hot to the touch and slightly raised. The area is still painful as well.; red rash on my arm 4 inches by 4 inches around the area of injection, hot to the touch and slightly raised. The area is still painful as well.; red rash on my arm 4 inches by 4 inches around the area of injection, hot to the touch and slightly raised. The area is still painful as well.; red rash on my arm 4 inches by 4 inches around the area of injection, hot to the touch and slightly raised. The area is still painful as well.; very sore arm; chills; aches all over; extreme fatigue; my arm remained sore and hot to the touch; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 17:30 (Lot number: EN 5318) at the age of 41 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: other_medical_history Asthma, Rosacea, High Cholesterol; "Rosacea" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "drug allergy" (unspecified if ongoing), notes: known_allergies Sulfa. Concomitant medication(s) included: PREVIFEM; ZOLOFT. Vaccination history included: Bnt162b2 (Dose:1, Lot number: EN5318, administration date: 12Feb2021,14:30, vaccine location: Left arm.), administration date: 12Feb2021, when the patient was 41 years old, for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 05Mar2021 10:00, outcome "not recovered", described as "very sore arm"; CHILLS (non-serious) with onset 05Mar2021 10:00, outcome "not recovered", described as "chills"; PAIN (non-serious) with onset 05Mar2021 10:00, outcome "not recovered", described as "aches all over"; FATIGUE (non-serious) with onset 05Mar2021 10:00, outcome "not recovered", described as "extreme fatigue"; FEELING HOT (non-serious) with onset 05Mar2021 10:00, outcome "not recovered", described as "my arm remained sore and hot to the touch"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE RASH (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 07Mar2021 10:00, outcome "not recovered" and all described as "red rash on my arm 4 inches by 4 inches around the area of injection, hot to the touch and slightly raised. The area is still painful as well."; ROSACEA (non-serious) with onset 08Mar2021 10:00, outcome "not recovered", described as "I also have rosacea, which has flared due to the vaccine, as of the next day after vaccine.". Therapeutic measures were not taken as a result of pain in extremity, chills, pain, fatigue, feeling hot, vaccination site erythema, vaccination site rash, vaccination site swelling, vaccination site pain, rosacea.  Additional information: The patient reported that,17 hours after 2nd vaccine dose, I experienced a very sore arm, followed by chills, aches all over, and extreme fatigue. This lasted for the following 8 hours. It is 10:00 am on Day 4 (08Mar) and the rash persists. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination was previfem, claritin 24 hours, previstatin and Zoloft. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.